Startups at Science Center’s Port Business Incubator Tackling Scientific and Technological Challenges

The two newest residents of the University City Science Center’s Port business incubator are taking on oral pain management and developing next-generation oncology therapeutics.

FyMed is a pharmaceutical company focused on drug development through sophisticated biomarker discovery methodologies in precision medicine. Starting with products for oral pain management, FyMed is utilizing novel markers based on immunomodulation therapy using NSAIDs. FyMed’s lab is located at 3624 Market Street.

Click here to read the full press details.


©2017 PACT All Rights Reserved